https://prabadinews.com/
  • October 9, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Monoclonal Antibodies: Streamlined Nonclinical Safety Studies

Monoclonal Antibodies: Streamlined Nonclinical Safety Studies

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled “Monoclonal Antibodies: Streamlined Nonclinical Safety Studies.”

administrator

Related Articles